EP1444260A2 - Proteines secretees et leur utilisation - Google Patents

Proteines secretees et leur utilisation

Info

Publication number
EP1444260A2
EP1444260A2 EP00932456A EP00932456A EP1444260A2 EP 1444260 A2 EP1444260 A2 EP 1444260A2 EP 00932456 A EP00932456 A EP 00932456A EP 00932456 A EP00932456 A EP 00932456A EP 1444260 A2 EP1444260 A2 EP 1444260A2
Authority
EP
European Patent Office
Prior art keywords
amino acid
seq
atcc
acid sequence
accession number
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00932456A
Other languages
German (de)
English (en)
Other versions
EP1444260A4 (fr
Inventor
Yang Pan
Kevin R. Leiby
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Publication of EP1444260A2 publication Critical patent/EP1444260A2/fr
Publication of EP1444260A4 publication Critical patent/EP1444260A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Abstract

L'invention concerne des molécules d'acide nucléique isolées, nommées TANGO 204, TANGO 206, TANGO 209, et A236, qui codent pour des protéines entièrement secrétées associées à la membrane. L'invention concerne également des molécules d'acide nucléique antisens, des vecteurs d'expression renfermant les molécules d'acide nucléique de l'invention, des cellules hôtes dans lesquelles ont été introduites les vecteurs d'expression, et des animaux transgéniques dans lesquels une molécule d'acide nucléique selon l'invention a été introduite ou interrompue. L'invention concerne en outre des polypeptides isolés, des polypeptides de fusion, des peptides et des anticorps antigéniques. L'invention concerne finalement des méthodes de diagnostic, de criblage et de thérapie qui reposent sur l'utilisation des compositions de l'invention.
EP00932456A 1999-05-14 2000-05-15 Proteines secretees et leur utilisation Withdrawn EP1444260A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US312359 1994-09-26
US31235999A 1999-05-14 1999-05-14
PCT/US2000/013361 WO2000069885A2 (fr) 1999-05-14 2000-05-15 Proteines secretees et leur utilisation

Publications (2)

Publication Number Publication Date
EP1444260A2 true EP1444260A2 (fr) 2004-08-11
EP1444260A4 EP1444260A4 (fr) 2004-08-25

Family

ID=23211103

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00932456A Withdrawn EP1444260A4 (fr) 1999-05-14 2000-05-15 Proteines secretees et leur utilisation

Country Status (3)

Country Link
EP (1) EP1444260A4 (fr)
AU (1) AU5017700A (fr)
WO (1) WO2000069885A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001239742A1 (en) * 2000-03-06 2001-09-17 Eli Lilly And Company Nucleic acids, encoding human crsp1 and uses thereof
EP1511506A4 (fr) * 2002-06-13 2006-12-06 Metabolex Inc Compositions et methodes permettant de prevenir, de traiter et de diagnostiquer des diabetes
PE20120341A1 (es) 2008-12-09 2012-04-24 Genentech Inc Anticuerpos anti-pd-l1 y su uso para mejorar la funcion de celulas t
GB201308117D0 (en) * 2013-05-06 2013-06-12 Univ Leuven Kath Inhibitor of calcifying disorders
RU2687461C1 (ru) * 2018-08-30 2019-05-13 Федеральное государственное бюджетное учреждение науки Институт химии Дальневосточного отделения Российской академии наук (ИХ ДВО РАН) Способ очистки нефтесодержащих вод и устройство для его осуществления

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL R. STRAUSBERG: "tk07e11.x1 NCI_CGAP_Lu24 Homo sapiens cDNA clone IMAGE: 2150348" XP002268317 Database accession no. AI458328 *

Also Published As

Publication number Publication date
EP1444260A4 (fr) 2004-08-25
WO2000069885A2 (fr) 2000-11-23
WO2000069885A8 (fr) 2004-05-13
AU5017700A (en) 2000-12-05

Similar Documents

Publication Publication Date Title
US8754199B2 (en) Tango 240 nucleic acids and uses thereof
US20060141575A1 (en) Secreted proteins and nucleic acids encoding them
EP1173456A1 (fr) Proteines secretees et acides nucleiques codant pour elles
EP1710299A2 (fr) Proteines secretées et polynucleotides codant pour ces proteines
WO2000039149A2 (fr) Proteines secretees et leurs utilisations
US6406884B1 (en) Secreted proteins and uses thereof
WO2000029438A9 (fr) Acides nucleiques et polypeptides et utilisations correspondantes
US7803564B2 (en) EGF-like nucleic acids and polypeptides and uses thereof
US6380382B1 (en) Gene encoding a protein having diagnostic, preventive, therapeutic, and other uses
EP1444260A2 (fr) Proteines secretees et leur utilisation
WO2000050443A9 (fr) Proteines secretees et leurs utilisations
US20050260702A1 (en) Novel integrin alpha subunit and uses thereof
WO2001023523A2 (fr) Proteines secretees et utilisation desdites proteines
WO2001000672A1 (fr) Proteines secretees et leurs utilisations
WO2000032746A2 (fr) Acides nucleiques et polypeptides netrinoïdes et ependyminoïdes et leurs utilisations
WO2000050442A2 (fr) Proteines secretees et utilisations
EP1141269A2 (fr) Proteines secretees et leurs utilisations
WO2000026227A9 (fr) Proteine apparentee aux ldl et son utilisation
WO2001081414A2 (fr) Nouvelle sous-unite $g(a) d'integrine et utilisations correspondantes
WO2001000644A1 (fr) Nouveaux genes codant pour des proteines s'utilisant a des fins de diagnostic, preventives, therapeutiques et autres

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011212

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20040709

17Q First examination report despatched

Effective date: 20061219

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070501